AFT, FORSYTH & COMPANY, INC. - SPDR SER TR ownership

SPDR SER TR's ticker is TFI and the CUSIP is 78468R721. A total of 259 filers reported holding SPDR SER TR in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AFT, FORSYTH & COMPANY, INC. ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2023$513,475
-5.3%
11,7500.0%0.38%
-2.3%
Q2 2023$542,380
-1.4%
11,7500.0%0.38%
-9.4%
Q1 2023$550,135
+2.6%
11,7500.0%0.42%
-7.0%
Q4 2022$536,035
+3.7%
11,7500.0%0.46%
-0.9%
Q3 2022$517,000
-4.1%
11,7500.0%0.46%
+6.0%
Q2 2022$539,000
-6.7%
11,750
-2.7%
0.44%
+18.2%
Q1 2022$578,000
-29.8%
12,080
-24.0%
0.37%
-12.8%
Q4 2021$823,000
+0.4%
15,9050.0%0.42%
-4.3%
Q3 2021$820,000
-1.1%
15,9050.0%0.44%
-0.5%
Q2 2021$829,000
+0.9%
15,9050.0%0.44%
-10.1%
Q1 2021$822,000
-7.3%
15,905
-5.9%
0.49%
-11.2%
Q4 2020$887,000
+1.0%
16,9050.0%0.56%
-15.0%
Q3 2020$878,000
-2.3%
16,905
-2.9%
0.65%
-13.9%
Q2 2020$899,000
-99.9%
17,4050.0%0.76%
-13.4%
Q1 2020$870,250,000
+98792.0%
17,4050.0%0.88%
+30.2%
Q4 2019$880,000
-0.2%
17,4050.0%0.67%
-7.8%
Q3 2019$882,000
+1.0%
17,4050.0%0.73%
+1.4%
Q2 2019$873,000
+0.9%
17,405
-0.9%
0.72%
-4.0%
Q1 2019$865,000
+2.4%
17,5550.0%0.75%
-10.9%
Q4 2018$845,000
+1.3%
17,5550.0%0.84%
+21.5%
Q3 2018$834,000
-1.0%
17,5550.0%0.69%
-6.4%
Q2 2018$842,000
-1.9%
17,555
-1.7%
0.74%
-7.7%
Q1 2018$858,000
-1.9%
17,8650.0%0.80%
-6.4%
Q4 2017$875,00017,8650.86%
Other shareholders
SPDR SER TR shareholders Q4 2019
NameSharesValueWeighting ↓
RITHOLTZ WEALTH MANAGEMENT 552,328$27,694,0004.73%
Private Wealth Group, LLC 82,026$4,113,0003.74%
Alliance Wealth Management Group 145,378$7,289,0003.57%
Financial Engines Advisors L.L.C. 10,685,694$548,606,0003.21%
Wealthfront Advisers LLC 5,704,091$286,003,0002.48%
BSW Wealth Partners 115,021$5,767,0002.18%
Towercrest Capital Management 145,378$7,289,0002.06%
NICOLET ADVISORY SERVICES, LLC 256,633$12,868,0001.96%
NewSquare Capital LLC 213,253$10,693,0001.95%
CX Institutional 221,702$11,116,0001.76%
View complete list of SPDR SER TR shareholders